The London Tunnels Amsterdam listing: A 'novelty investment' or another loss for the UK?

Industry split on relocation

Cristian Angeloni
clock • 3 min read

The decision by The London Tunnels to list on the Euronext Amsterdam took the industry somewhat by surprise considering the company had set out plans in January to float on the London Stock Exchange.

Trading is supposed to commence today (27 June), with a market capitalisation of around £130m and a fundraising target of £30m, although £24.5m has already been "irrevocably committed" by 15 investors. The move left industry players split as to what the rationale behind shunning London for a European market may actually be. Although the FTSE All-Share was hardly affected by the decision, considering it was up 0.5% when the London Tunnels revealed its plans on Monday (24 June), Russ Mould, investment director at AJ Bell, noted the small size of the deal could be one of the reasons behi...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Companies

Monzo fined £21m by FCA for failings in financial crime controls

Monzo fined £21m by FCA for failings in financial crime controls

Around 34,000 high-risk clients onboarded

Linus Uhlig
clock 08 July 2025 • 2 min read
Citi becomes minority investor in HANetf

Citi becomes minority investor in HANetf

Growing interest in European ETFs

Patrick Brusnahan
clock 03 July 2025 • 2 min read
AstraZeneca CEO mulls moving listing to the US – reports

AstraZeneca CEO mulls moving listing to the US – reports

Latest blow to LSE

Linus Uhlig
clock 02 July 2025 • 1 min read
Trustpilot